NovoCure Ltd — Director's Dealing 2018

Mar 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-02-27

Reporting Person: Ambrogi Michael J. (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-27	Options to Buy Ordinary Shares	$21.15	A	135172	Acquired	2028-02-27	Ordinary Shares (135172)	Direct
2018-02-27	Restricted Stock Unit	$	A	18519	Acquired		Ordinary Shares (18519)	Direct

Footnotes

F1: Options to buy 135,172 ordinary shares will vest and become exercisable in equal installments on each of February 27, 2019, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates.

F2: Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share.

F3: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates.